
The US Food and Drug Administration (FDA) reported on 19 October 2026 that seven of 195 lemon juice samples breached the US standard of identity. All seven were imported samples. The work forms part of the agency’s surveillance for economically motivated adulteration.
What the sampling found
The assignment ran from 2022 to 2025 and covered domestic and imported products. The FDA tested for indicators of ingredients inconsistent with the standard, including added sweeteners, citric acid, excess water and juice from other sources. Violations represented 4.5% of imported samples and 3.6% of all samples tested. The agency refused entry to the associated shipments and placed the relevant firms and products on Import Alert 99-47.
What the results mean for procurement and quality
The percentages describe the samples collected for this assignment. The release does not establish the prevalence of adulteration across the US lemon juice market.
Importers and manufacturers can use the findings to review the vulnerability assessment for lemon juice, including supplier changes and unusually low offers. Match the purchase specification to the product’s intended US identity, confirm the source and formulation through supplier records, and agree with the laboratory which tests can address the specific authenticity concerns. Keep the results linked to supplier and lot records so any follow-up can be traced.
Primary source
FDA lemon juice sampling assignment results, 19 October 2026